Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 063295/0386 | |
| Pages: | 6 |
| | Recorded: | 04/11/2023 | | |
| Attorney Dkt #: | 059541-000099USPX |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ERROR IN ASSIGNEE NAME NANJING SHUNXIN PHARMACEUTICALS CO., LTD. OF CHITAI TIANQING PHARMACEUTICAL GROUP PREVIOUSLY RECORDED ON REEL 063148 FRAME 0509. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTIVE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18040498
|
Filing Dt:
|
02/03/2023
|
|
Publication #:
|
|
Pub Dt:
|
12/21/2023
| | | | |
|
Title:
|
ANTIBODY DRUG CONJUGATE
|
|
|
Assignees
|
|
|
|
|
| NO. 369 YUZHOU SOUTH RD. |
| LIANYUNGANG CITY, JIANGSU PROVINCE, CHINA 222062 |
|
|
|
|
|
| NO. 1099 FUYING ROAD, JIANGNING HIGH-TECH ZONE |
| JIANGNING DISTRICT |
| NANJING CITY, JIANGSU PROVINCE, CHINA 211100 |
|
|
Correspondence name and address
|
| |
NIXON PEABODY LLP
|
| |
70 WEST MADISON STREET, SUITE 5200
|
| |
CHICAGO, IL 60602
|
Search Results as of:
05/23/2024 06:46 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
